Sign up for The Agenda — Them’s news and politics newsletter, delivered to your inbox every Thursday.
The following weekly digest is written and compiled by the Trans Formations Project, a grassroots nonprofit dedicated to tracking and educating about the anti-trans legislative crisis currently sweeping the United States. You can follow their work and latest updates via Twitter, Instagram, TikTok, Tumblr, and Facebook.
Hello readers. It’s Friday, October 4, 2024.
As a reminder, legislative sessions are different for each state — you can keep track of your state’s legislative session here. Currently, bill progressions have slowed or halted entirely following the conclusion of legislative sessions in most states.
This week: no new bills were introduced, no bills progressed.
To note: If you notice the newsletter looks cut off, or you have issues viewing the newsletter, click the small “View Entire Message” button at the very bottom of your email. You can also check our website, where we keep an archive of every published newsletter. Thank you for supporting TFP’s work!
Editorial Feature
Editorial Preview: The Cass Report
Next week, we’ll begin a multi-segment feature on the Cass Report, Dr. Hilary Cass’ April 2024 review of the U.K. National Health Service’s (NHS) gender identity care. The NHS commissioned this independent review following an increase in referrals to gender identity clinics, up significantly since 2014.
Dr. Cass’ report is subdivided into sections: approach; context; understanding the patient cohort; clinical approach & clinical management; and service model. In these sections, Cass breaks down the existing NHS model for providing gender-affirming care, focusing in particular on the needs of minor patients. Cass concludes her review with thirty-two recommendations that she believes will improve future NHS gender-affirming services.
In our first editorial segment, next week, we’ll break down the report in full, analyzing the rhetoric and arguments used. Dr. Cass’ report has faced both criticism from trans activists and praise from medical professionals, positioning it as a controversial document in the ongoing fight for trans healthcare rights. The report’s effects have been far-reaching, impacting policy worldwide. In our second and third editorial segments, soon to follow, we’ll outline the influence this report has had on legislation in the U.K. and U.S., respectively.
The Things We Won
